Professor, Pathology, UCSF School of Medicine
Pathology
Dr. Stephen L. Nishimura, MD
|
|
Give Review
Doctor Stephen L. Nishimura, MD practices Pathology. He studied medicine at University of Vermont College of Medicine. Stephen Nishimura is a published doctor. He published 33 publications, including: 'A Critical Role for Dendritic Cells in the Evolution of IL-1-Mediated Murine Airway Disease.'
Publications
- A Critical Role for Dendritic Cells in the Evolution of IL-1β-Mediated Murine Airway Disease.
- Selective Targeting of TGF-β Activation to Treat Fibroinflammatory Airway Disease.
- Functional genomic screen identifies novel mediators of collagen uptake.
- Isomers in ^{128}pd and ^{126}pd: evidence for a robust shell closure at the neutron magic number 82 in exotic palladium isotopes.
- Interleukin-1{beta} induces increased transcriptional activation of the transforming growth factor-{beta} activating integrin subunit {beta}8 through altering chromati...
- Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8-mediated activation of TGF-β.
- Insulin-Dependent Phosphatidylinositol 3-Kinase/Akt and ERK Signaling Pathways Inhibit TLR3-Mediated Human Bronchial Epithelial Cell Apoptosis.
- Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells.
- Transcription of the transforming growth factor beta activating integrin beta8 subunit is regulated by SP3, AP-1, and the p38 pathway.
- Reduced expression of integrin alphavbeta8 is associated with brain arteriovenous malformation pathogenesis.
- Fibrogenic reactions in lung disease.
- Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8.
- Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders.
- mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids.
- Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodies.
- Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients.
- Activation of transforming growth factor-beta by the integrin alphavbeta8 delays epithelial wound closure.
- Integrin-mediated transforming growth factor-beta activation regulates homeostasis of the pulmonary epithelial-mesenchymal trophic unit.
- A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance.
- Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: an angiogenic control switch.
- A 50-A separation of the integrin alpha v beta 3 extracellular domain C termini reveals an intermediate activation state.
- Integrin alphavbeta8-mediated activation of transforming growth factor-beta inhibits human airway epithelial proliferation in intact bronchial tissue.
- Fas activation induces renal tubular epithelial cell beta 8 integrin expression and function in the absence of apoptosis.
- The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1.
- Low prevalence of chronic beryllium disease among workers at a nuclear weapons research and development facility.
- Case report: a case of wood-smoke-related pulmonary disease.
- Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence.
- Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus.
- Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection.
- Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection.
- IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B.
- Restoring transcription factor HoxA5 expression inhibits the growth of experimental hemangiomas in the brain.
Schools
University of Vermont College of Medicine
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
UCSF -
University of Vermont College of Medicine
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Thomas J. Eiman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ari B. Molofsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria M. Patino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Karlon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rosa S. Rosen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zohreh L. Tabatabai, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|